NCT01790464View on ClinicalTrials.gov

Glossopharyngeal Nerve Block for Awake Intubation

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

April 30, 2014

Conditions
Morbid Obesity
Interventions
DRUG

2% Lidocaine

2% lidocaine and peritonsillar instillation of gauze soaked with 2% lidocaine (Glossopharyngeal Group).

DRUG

placebo

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT01790464 - Glossopharyngeal Nerve Block for Awake Intubation | Biotech Hunter | Biotech Hunter